These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
6. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Wen J; Shi JL; Shen DH; Chen YX; Song QJ Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451 [TBL] [Abstract][Full Text] [Related]
7. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388 [TBL] [Abstract][Full Text] [Related]
8. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma]. Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294 [No Abstract] [Full Text] [Related]
9. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers. Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744 [TBL] [Abstract][Full Text] [Related]
10. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912 [TBL] [Abstract][Full Text] [Related]
11. [Fallopian tube: the dark face of pelvic carcinogenesis]. Watkin E; Devouassoux-Shisheboran M Ann Pathol; 2011 Oct; 31(5):345-52. PubMed ID: 21982240 [TBL] [Abstract][Full Text] [Related]
12. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma]. Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343 [TBL] [Abstract][Full Text] [Related]
13. A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers. Cass I; Walts AE; Barbuto D; Lester J; Karlan B Gynecol Oncol; 2014 Sep; 134(3):492-7. PubMed ID: 25026639 [TBL] [Abstract][Full Text] [Related]
14. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391 [TBL] [Abstract][Full Text] [Related]
15. "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Seidman JD; Zhao P; Yemelyanova A Gynecol Oncol; 2011 Mar; 120(3):470-3. PubMed ID: 21159368 [TBL] [Abstract][Full Text] [Related]
16. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol? Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507 [TBL] [Abstract][Full Text] [Related]
17. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma]. Guo DH; Pang SJ; Shen Y; Li Y Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501 [TBL] [Abstract][Full Text] [Related]
18. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum]. Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778 [TBL] [Abstract][Full Text] [Related]
19. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum. Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819 [TBL] [Abstract][Full Text] [Related]